Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life. (17th August 2016)

• Record Type: Journal Article
• Authors: Lane, Athene; Metcalfe, Chris; Young, Grace J.; Peters, Tim J.; Blazeby, Jane; Avery, Kerry N. L.; Dedman, Daniel; Down, Liz; Mason, Malcolm D.; Neal, David E.; Hamdy, Freddie C.; Donovan, Jenny L.
• Other Names: Bonnington Sue investigator.; Bradshaw Lynne investigator.; Cooper Debbie investigator.; Elliott Emma investigator.; Herbert Pippa investigator.; Holding Peter investigator.; Howson Joanne investigator.; Jones Mandy investigator.; Lennon Teresa investigator.; Lyons Norma investigator.; Moody Hilary investigator.; Plumb Claire investigator.; O'Sullivan Tricia investigator.; Salter Liz investigator.; Tidball Sarah investigator.; Thompson Pauline investigator.; Adam Tonia investigator.; Askew Sarah investigator.; Atkinson Sharon investigator.; Baynes Tim investigator.; Blaikie Jan investigator.; Brain Carole investigator.; Breen Viv investigator.; Brunt Sarah investigator.; Bryne Sean investigator.; Bythem Jo investigator.; Clarke Jenny investigator.; Cloete Jenny investigator.; Dark Susan investigator.; Davis Gill investigator.; De La Rue Rachael investigator.; Denizot Jane investigator.; Dewhurst Elspeth investigator.; Dimes Anna investigator.; Dixon Nicola investigator.; Ebbs Penny investigator.; Emmerson Ingrid investigator.; Ferguson Jill investigator.; Gadd Ali investigator.; Geoghegan Lisa investigator.; Grant Alison investigator.; Grant Collette investigator.; Gray Catherine investigator.; Godfrey Rosemary investigator.; Goodwin Louise investigator.; Hall Susie investigator.; Hart Liz investigator.; Harvey Andrew investigator.; Hoult Chloe investigator.; Hawkins Sarah investigator.; Holling Sharon investigator.; Innes Alastair investigator.; Kilner Sue investigator.; Marshall Fiona investigator.; Mellen Louise investigator.; Moore Andrea investigator.; Napier Sally investigator.; Needham Julie investigator.; Pearse Kevin investigator.; Pisa Anna investigator.; Rees Mark investigator.; Richards Elliw investigator.; Robson Lindsay investigator.; Roxburgh Janet investigator.; Samuel Nikki investigator.; Sharkey Irene investigator.; Slater Michael investigator.; Smith Donna investigator.; Taggart Pippa investigator.; Taylor Helen investigator.; Taylor Vicky investigator.; Thomas Ayesha investigator.; Tomkies Briony investigator.; Trewick Nicola investigator.; Ward Claire investigator.; Walker Christy investigator.; Williams Ayesha investigator.; Woodhouse Colin investigator.; Wyber Elizabeth investigator.; Aning Jonathan investigator.; Bollina Prasad investigator.; Catto Jim investigator.; Doble Andrew investigator.; Doherty Alan investigator.; Durkan Garett investigator.; Gillatt David investigator.; Hughes Owen investigator.; Kocklebergh Roger investigator.; Kouparis Anthony investigator.; Kynaston Howard investigator.; Leung Hing investigator.; Mariappan Param investigator.; McNeill Alan investigator.; Paez Edgar investigator.; Paul Alan investigator.; Persad Raj investigator.; Powell Philip investigator.; Prescott Stephen investigator.; Rosario Derek investigator.; Rowe Edward investigator.; Schwaibold Hartwig investigator.; Tulloch David investigator.; Wallace Mike investigator.; Bahl Amit investigator.; Benson Richard investigator.; Beresford Mark investigator.; Ferguson Catherine investigator.; Graham John investigator.; Herbert Chris investigator.; Howard Grahame investigator.; James Nick investigator.; Law Alastair investigator.; Loughrey Carmel investigator.; McClaren Duncan investigator.; Patterson Helen investigator.; Pedley Ian investigator.; Robinson Angus investigator.; Russell Simon investigator.; Staffurth John investigator.; Symonds Paul investigator.; Thanvi Narottam investigator.; Vasanthan Subramaniam investigator.; Wilson Paula investigator.; Appleby Helen investigator.; Ash Dominic investigator.; Aston Dean investigator.; Bolton Steven investigator.; Chalmers Graham investigator.; Conway John investigator.; Early Nick investigator.; Geater Tony investigator.; Goddall Lynda investigator.; Heymann Claire investigator.; Hicks Deborah investigator.; Jones Liza investigator.; Lamb Susan investigator.; Lambert Geoff investigator.; Lawrence Gill investigator.; Lewis Geraint investigator.; Lilley John investigator.; MacLeod Aileen investigator.; Massey Pauline investigator.; McQueen Alison investigator.; Moore Rollo investigator.; Penketh Lynda investigator.; Potterton Janet investigator.; Roberts Neil investigator.; Showler Helen investigator.; Slade Stephen investigator.; Steele Alasdair investigator.; Swinscoe James investigator.; Tiffany Marie investigator.; Townley John investigator.; Treeby Jo investigator.; Wilkinson Joyce investigator.; Williams Lorraine investigator.; Wills Lucy investigator.; Woodley Owain investigator.; Yarrow Sue investigator.; Bhattarai Selina investigator.; Deshmukh Neeta investigator.; Dormer John investigator.; Fernando Malee investigator.; Goepel John investigator.; Griffiths David investigator.; Grigor Ken investigator.; Mayer Nick investigator.; Oxley Jon investigator.; Robinson Mary investigator.; Varma Murali investigator.; Warren Anne investigator.; Brindle Lucy investigator.; Davis Michael investigator.; Khazragui Hanan investigator.; Noble Sian investigator.; Taylor Hilary investigator.; Tazewell Marta investigator.; Turner Emma investigator.; Wade Julia investigator.; Walsh Eleanor investigator.; Baker Susan investigator.; Bellis‐Sheldon Elizabeth investigator.; Bougard Chantal investigator.; Bowtell Joanne investigator.; Brewer Catherine investigator.; Burton Chris investigator.; Charlton Jennie investigator.; Christoforou Nicholas investigator.; Clark Rebecca investigator.; Coull Susan investigator.; Croker Christine investigator.; Currer Rosemary investigator.; Daisey Claire investigator.; Delaney Gill investigator.; Donohue Rose investigator.; Drew Jane investigator.; Farmer Rebecca investigator.; Fry Susan investigator.; Haddow Jean investigator.; Hale Alex investigator.; Halpin Susan investigator.; Harris Belle investigator.; Hattrick Barbara investigator.; Holmes Sharon investigator.; Hunt Helen investigator.; Jackson Vicky investigator.; Johnson Donna investigator.; Le Butt Mandy investigator.; Leworthy Jo investigator.; Liddiatt Tanya investigator.; Martin Alex investigator.; Mauree Jainee investigator.; Moore Susan investigator.; Moulam Gill investigator.; Mutch Jackie investigator.; Nash Alena investigator.; Parker Kathleen investigator.; Pawsey Christopher investigator.; Purdie Michelle investigator.; Robson Teresa investigator.; Smith Lynne investigator.; Snoeck Jo investigator.; Stenton Carole investigator.; Steuart‐Feilding Tom investigator.; Sully Chris investigator.; Sutton Caroline investigator.; Torrington Carol investigator.; Wilkins Zoe investigator.; Williams Sharon investigator.; Wilson Andrea investigator.; Grant Adrian investigator.; Roberts Ian investigator.; Ashby Deborah investigator.; Cowan Richard investigator.; Fayers Peter investigator.; Mellon Killian investigator.; N'Dow James investigator.; O'Brien Tim investigator.; Sokhal Michael investigator.; Baum Michael investigator.; Adolfson Jan investigator.; Albertsen Peter investigator.; Dearnaley David investigator.; Schroeder Fritz investigator.; Roberts Tracy investigator.; Zietman Anthony investigator.;
• Is Part Of: BJU international. Volume 118:Number 6(2016:Sep.)
• Page Start: 869
• Page End: 879
• Publication Date: 2016-08-17
• Subjects: prostate cancer -- treatment -- functional status -- quality of life -- protect trial -- ISRCTN 20141297; Genitourinary organs -- Diseases -- Periodicals; Genitourinary organs -- Surgery -- Periodicals; Urology -- Periodicals; 616.6
• DOI: 10.1111/bju.13582
• Languages: English
• ISSNs: 1464-4096

Abstract

Abstract : Objectives: To present the baseline patient‐reported outcome measures (PROMs) in the Prostate Testing for Cancer and Treatment (ProtecT) randomized trial comparing active monitoring, radical prostatectomy and external‐beam conformal radiotherapy for localized prostate cancer and to compare results with other populations. Materials and Methods: A total of 1643 randomized men, aged 50–69 years and diagnosed with clinically localized disease identified by prostate‐specific antigen (PSA) testing, in nine UK cities in the period 1999–2009 were included. Validated PROMs for disease‐specific (urinary, bowel and sexual function) and condition‐specific impact on quality of life (Expanded Prostate Index Composite [EPIC], 2005 onwards; International Consultation on Incontinence Questionnaire‐Urinary Incontinence [ICIQ‐UI], 2001 onwards; the International Continence Society short‐form male survey [ICSmaleSF]; anxiety and depression (Hospital Anxiety and Depression Scale [HADS]), generic mental and physical health (12‐item short‐form health survey [SF‐12]; EuroQol quality‐of‐life survey, the EQ‐5D‐3L) were assessed at prostate biopsy clinics before randomization. Descriptive statistics are presented by treatment allocation and by men's age at biopsy and PSA testing time points for selected measures. Results: A total of 1438 participants completed biopsy questionnaires (88%) and 77–88% of these were analysed for individual PROMs. Fewer than 1% of participants were using pads daily (5/754). Storage lower urinary tract symptoms were frequent (e.g. nocturia 22%, 312/1423). Bowel symptoms were rare, except for loose stools (16%, 118/754). One third of participants reported erectile dysfunction (241/735) and for 16% (118/731) this was a moderate or large problem. Depression was infrequent (80/1399, 6%) but 20% of participants (278/1403) reported anxiety. Sexual function and bother were markedly worse in older men (65–70 years), whilst urinary bother and physical health were somewhat worse than in younger men (49–54 years, all P < 0.001). Bowel health, urinary function and depression were unaltered by age, whilst mental health and anxiety were better in older men ( P < 0.001). Only minor differences existed in mental or physical health, anxiety and depression between PSA testing and biopsy assessments. Conclusion: The ProtecT trial baseline PROMs response rates were high. Symptom frequencies and generic quality of life were similar to those observed in populations screened for prostate cancer and control subjects without cancer.